CTLA-4 is required for the induction of high dose oral tolerance

International Immunology

Volumn 10, Issue 4, 1998, Pages 491-498

  Samoilova, Elena B ^a   Horton, Jennifer L ^a   Zhang, Haidi ^a   Khoury, Samia J ^b   Weiner, Howard L ^b   Chen, Youhai ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD28; CD80 CD86; Co stimuiation; CTLA 4; Oral tolerance

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNE TOLERANCE; IMMUNOCONJUGATES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031944923     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.4.491     Document Type: Article

References (51)

1. Gross, J. A., Callas, E. and Allison, J. P. 1992. Identification and distribution of the co-stimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
2. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H. and Allison, J. P. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
3. June, C. H., Ledbetter, J. A., Linsley, P. S. and Thompson, C. B. 1990. Role of the CD28 receptor in T-cell activation, Immunol. Today 11:211.
4. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A. 1991. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
5. Schwartz, R. H. 1992. Co-stimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
6. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
7. Perrin, P. J., Scott, D., Quigley, L., Albert, P. S., Feder, O., Gray, G. S., Abe, R., June, C. H. and Racke, M. K. 1995. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1481-1490.
8. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell co-stimulation. Immunity 2:555.
9. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985.
10. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
11. Wells, H. G. 1911. Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg. J. Infect. Dis. 8:147-171.
12. Mowat, A. M. 1987. The regulation of immune responses to dietary protein antigens. Immunol. Today 8:93.
13. Weiner, H. L., Friedman, A., Miller, F., Khoury, S. J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E. and Hafler, D. A. 1994. Oral tolerance: immunologic mechanisms and treatment of murine and human organ specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
14. Thompson, H. S. G. and Staines, N. A. 1986. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 64:581.
15. Nagler-Anderson, C., Bober, L. A., Robinson, M. E., Siskind, G. W. and Thorbeke, F. J. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl Acad. Sci. USA 83:7443.
16. Higgins, P. and Weiner, H. L. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:440.
17. Bitar, D. M. and Whitacre, C. C. 1988. Suppression of autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112:364.
18. Whitacre, C. C., Gienapp, I. E., Orosz, C. G. and Bitar, D. 1991. Oral tolerance in experimental autoimmune encephalomyelits. III. Evidence for clonal anergy. J. Immunol. 147:2155-2163.
19. Sayegh, M. H., Khoury, S. J., Hancock, W. H., Weiner, H. L. and Carpenter, C. B. 1992. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc. Natl Acad. Sci. USA 89:7762.
20. Sayegh, M. H., Zhang, Z. J., Hancock, W. W., Kwok, C. A., Carpenter, C. B. and Weiner, H. L. 1992. Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation 53:163.
21. Nussenblatt, R. B., Caspi, R. R., Mahdi, R., Chan, C. C., Roberge, F., Lider, O. and Weiner, H. L. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144:1689.
22. Rizzo, L. V., Miller-Rivero, N. E., Chan, C. C., Wiggert, B., Nussenblatt, R. B. and Caspi, R. R. 1994. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest. 94:1668.
23. Zhang, J. A., Davidson, L., Eisenbarth, G. and Weiner, H. L. 1991. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl Acad. Sci. USA 88:10252.
24. Zhang, J. Z., Lee, C. S. Y., Lider, O. and Weiner, H. L. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145:2489.
25. Miller. A., Lider, O., Roberts, A. B., Sporn, M. B. and Weiner, H. L. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc. Natl Acad. Sci. USA 89:421.
26. Friedman, A. and Weiner, H. L. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl Acad. Sci. USA 91:6688.
27. Gregerson, D. S., Obritsch, W. F. and Donoso, L. A. 1993. Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low versus high dose feeding protocols. J. Immunol. 151:5751.
28. Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A. and Weiner, H. L. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
29. Melamed, D. and Friedman, A. 1993. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23:935.
30. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
31. Mitchison, N. A. 1964. Induction of immunological paralysis in two zones of dosage. Proc. Roy. Soc. Biol. 161:275.
32. Mitchison, N. A. 1992. Specialization, tolerance, memory, competition, latency, and strife among T cells. Annu. Rev. Immunol. 10:1.
33. Holt, P. G. and Leivers, S. 1982. Tolerance induction via antigen inhalation: isotype specificity, stability, and involvement of suppressor T cells. Int. Arch. Allergy Appl. Immunol. 67:155.
34. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
35. Burstein, H. J., Shea, C. M. and Abbas, A. K. 1992. Aqueous antigens induce in vivo tolerance selectivity in IL-2 and IFN-γ-producing (Th1) cells. J. Immunol. 148:3687.
36. Gautam, S. C., Chikkala, N. F. and Battisto, J. R. 1990. Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population. Cell. Immunol 125:437.
37. lo Thymocytes in vivo. Science 250:1720.
38. Chen, Y., Inobe, J.-i. and Weiner, H. L. 1995. Induction of oral tolerance to MBP in CDS-depleted mice. J. Immunol. 155:910.
39. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
40. Freeman, G. J., Borriello, F., Modes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K. S., Laszlo, G., Lombard, D. B., Wang, S., Gray, G. S., Nadler, L. M. and Sharpe, A. H. 1993. Murine B7-2, an alternative CTLA-4 counter-receptor that co-stimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185.
41. Lenschow, D. J., Zeng, Y., Thistlewaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A. 1992. Longterm survival of xenogenic pancreatic islet grafts induced by CTLA-4-Ig. Science 257:789.
42. Cross, A., Girard, T. J., Giacoletto, K. S., Evans, R. J. and Karr, R. W. 1994. CTLA-4-Ig treatment prevents murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 54:P01.01.
43. Perrin, P. J., Maldonado, J. H., Davis, T. A., June. C. H. and Racke, M. K. 1996. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333.
44. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X.-Y., Rennert, P. D., Gray, G. S., Gribben, J. G. and Nadler, L. M. 1995. B7-1 and B7-2 do not deliver identical co-stimulatory signals, since B7-2 but not B7-1 preferentially co-stimulates the initial production of IL-4. Immunity 2:523.
45. Vidard, L. J. C. L. and Benacerraf, B. 1994. Specific T-cell tolerance may be preceded by a primary response. Proc. Natl Acad. Sci. USA 91:5627.
46. Sethna, M. P., van Parijs, L., Sharpe, A. H., Abbas, A. K. and Freeman, G. J. 1994. A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1:415.
47. Boehme, S. A. and Lenardo, M. J. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23:1552.
48. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
49. Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B. and Abbas, A. K. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
50. Bluestone, J. A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance. J. Immunol. 158:1989.
51. + T cells from tolerance induction by the super-antigen staphylococcal enterotoxin B. Eur. J. Immunol. 26:858.